Pietro Maffei Selected Research

Alstrom Syndrome

1/2021	Neurocognitive assessment and DNA sequencing expand the phenotype and genotype spectrum of Alström syndrome.
8/2020	Cochlear Implants in Alström Syndrome.
1/2014	GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance.
2/2012	The progression from obesity to type 2 diabetes in Alström syndrome.
1/2012	The Alström syndrome protein, ALMS1, interacts with α-actinin and components of the endosome recycling pathway.
5/2011	Alström syndrome: genetics and clinical overview.
5/2010	High-resolution spectral domain optical coherence tomography images of Alström syndrome.
3/2009	Protection from clinical peripheral sensory neuropathy in Alström syndrome in contrast to early-onset type 2 diabetes.
12/2007	Alström syndrome.
5/2002	Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Maffei Research Topics

Disease

17	Acromegaly 06/2022 - 03/2002
10	Alstrom Syndrome 01/2021 - 05/2002
8	Insulin Resistance 02/2017 - 08/2004
4	Pituitary Neoplasms (Pituitary Adenoma) 02/2022 - 05/2011
4	Neoplasms (Cancer) 02/2022 - 08/2015
4	Obesity 01/2020 - 02/2007
3	Hyperinsulinism (Hyperinsulinemia) 02/2017 - 02/2012
3	Hypogonadism (Hypergonadotropic Hypogonadism) 06/2016 - 10/2002
3	Hypertension (High Blood Pressure) 12/2014 - 12/2006
2	Diabetes Mellitus 01/2021 - 08/2013
2	COVID-19 10/2020 - 01/2020
2	Cushing Syndrome 03/2017 - 02/2013
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 02/2017 - 08/2004
2	Type 2 Diabetes Mellitus (MODY) 08/2015 - 02/2012
2	Dyslipidemias (Dyslipidemia) 08/2015 - 05/2011
2	Glucose Intolerance 01/2014 - 02/2012
1	Chronic Disease (Chronic Diseases) 02/2022
1	Prolactinoma (Prolactinomas) 02/2022
1	Hyperthyroidism 04/2020
1	Dementia (Dementias) 01/2020
1	Hyperkalemia 01/2020
1	Infections 01/2020
1	Overweight 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Megaloblastic Anemia 01/2017
1	Optic Atrophy 01/2017
1	Wolfram Syndrome (Syndrome, Wolfram) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 08/2015
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 08/2015
1	Metabolic Diseases (Metabolic Disease) 01/2014
1	Body Weight (Weight, Body) 01/2014
1	Confusion (Bewilderment) 08/2013
1	Rare Diseases (Rare Disease) 08/2013
1	Fibrosis (Cirrhosis) 08/2013
1	Weight Loss (Weight Reduction) 02/2012
1	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 05/2011
1	Ciliopathies 05/2011
1	Cone-Rod Dystrophies 05/2010
1	Hemorrhage 01/2008
1	Aortic Rupture 01/2008
1	Heart Failure 02/2007
1	Insulinoma 12/2005
1	Carcinoid Tumor (Carcinoid) 04/2005

Drug/Important Bio-Agent (IBA)

10	Insulin (Novolin)FDA Link 01/2021 - 12/2005
8	Insulin-Like Growth Factor I (IGF-1)IBA 06/2022 - 12/2006
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2012
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019 - 03/2002
3	Growth Hormone (Somatotropin)IBA 02/2022 - 10/2002
2	pegvisomant FDA LinkGeneric 06/2022 - 08/2006
2	methylamphotericin B (AME)IBA 01/2020 - 01/2020
2	Hormones (Hormone)IBA 01/2018 - 12/2005
2	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2017 - 02/2013
2	TungstenIBA 01/2017 - 08/2013
2	lanreotide (Somatuline)FDA Link 01/2017 - 03/2002
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2014 - 08/2004
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 05/2011
1	Insulin-Like PeptidesIBA 02/2022
1	ProlactinIBA 02/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2020
1	Transaminases (Aminotransferases)IBA 10/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2020
1	Methimazole (Thiamazole)FDA LinkGeneric 04/2020
1	AldosteroneIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2017
1	Thiamine (Aneurin)FDA Link 01/2017
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2017
1	LigandsIBA 01/2017
1	ThiazolidinedionesIBA 08/2015
1	Metformin (Glucophage)FDA LinkGeneric 08/2015
1	Niacin (Nicotinic Acid)FDA LinkGeneric 08/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 08/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015
1	erucylphosphocholineIBA 12/2014
1	GadoliniumIBA 08/2013
1	Messenger RNA (mRNA)IBA 12/2012
1	Insulin ReceptorIBA 12/2012
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2012
1	ActininIBA 01/2012
1	Amino Acids FDA Link 05/2011
1	Retinaldehyde (Retinal)IBA 05/2010
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2010
1	Rosiglitazone (Avandia)FDA Link 06/2008
1	Deoxyglucose (2 Deoxy D glucose)IBA 06/2008
1	Testosterone (Sustanon)FDA Link 02/2007
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2006
1	SodiumIBA 12/2006
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 08/2006

Therapy/Procedure

12	Therapeutics 02/2022 - 03/2002
2	Radiotherapy 09/2018 - 05/2011
1	Cochlear Implants (Cochlear Implant) 08/2020
1	Thyroidectomy 04/2020
1	Noninvasive Ventilation 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Secondary Prevention 08/2015